Feedback / Questions
GSK4527226 - GSK
latozinemab (GSK4527223) - GSK
https://www.globenewswire.com/news-release/2025/01/13/3008414/0/en/Alector-Reports-on-Recent-Progress-and-Outlines-Strategic-Priorities-for-2025.html
Jan 13, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next